Creighton et al. identified genes commonly regulated by overexpression of EGFR, or constitutively active HER2, RAF, or MEK in breast cell lines as a "MAPK signature", which showed hyperactivation of the MAPK pathway in estrogen receptor (ER) negative breast cancers [35]. The gene discussed is ERBB2; the disease is breast cancer.